We compared FAK and PYK2 mRNA levels in B lymphocytes collected from the PB of healthy donors (n = 10), patients with the pre‐leukaemic state MBL (n = 5)29 and patients with overt CLL (n = 36; Figure 2B,C).30 This evidence concerns the gene PTK2B and B-cell chronic lymphocytic leukemia.